What is NDC 70710-2142?

70710-2142 is the product NDC for Carbidopa and Levodopa, Carbidopa 61.25 mg/1; Levodopa 245 mg/1 capsule, extended release, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Carbidopa and Levodopa?

97 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Carbidopa and Levodopa NDC 70710-2142

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-2142Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-2142Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-2142-1	7071021420170710214201	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70710-2142-1)Marketed from Oct 20, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carbidopa and Levodopa
Generic name (nonproprietary): carbidopa and levodopa
Active ingredients: Carbidopa — 61.25 mg/1Levodopa — 245 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 70710
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 203312
Marketing start: Oct 20, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Aromatic (Chemical structure)
Identifiers: Product ID 70710-2142_9f66a828-7712-41a2-8380-682a3bbe50d6SPL ID 9f66a828-7712-41a2-8380-682a3bbe50d6SPL set ID 74e7f96b-de31-4e3c-b32d-11421b291d4eRxCUI 1600773, 1600775, 1600914, 1600916UNII MNX7R8C5VO, 46627O600J
Pharmacologic class: Aromatic Amino Acid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710214201 followed by a unit qualifier and the quantity

Package 70710-2142-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 14, 2025.

Indications (excerpt from the label)

Carbidopa and levodopa extended-release capsules are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. Carbidopa and levodopa extended-release capsule is a combination of carbidopa (an aromatic amino acid decarboxylation inhibitor) and levodopa (an aromatic amino acid) indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70710-2142

What is NDC 70710-2142?: 70710-2142 is the product NDC for Carbidopa and Levodopa, Carbidopa 61.25 mg/1; Levodopa 245 mg/1 capsule, extended release, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Carbidopa and Levodopa.
What is the active ingredient?: Carbidopa, Levodopa.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Carbidopa and Levodopa?: 97 other product NDCs are listed under this name. See all Carbidopa and Levodopa NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Carbidopa and Levodopa NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Carbidopa and Levodopa	Carbidopa 25 mg/1; Levodopa 250 mg/1	TabletOral	Coupler LLC	67046-1689	67046-1689-03
Carbidopa and Levodopa	Carbidopa 25 mg/1; Levodopa 100 mg/1	TabletOral	AvPAK	50268-202	50268-0202-15
Carbidopa and Levodopa	Carbidopa 48.75 mg/1; Levodopa 195 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4621	70518-4621-00
Carbidopa and Levodopa	Carbidopa 23.75 mg/1; Levodopa 95 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4618	70518-4618-00
Carbidopa and Levodopa	Carbidopa 25 mg/1; Levodopa 250 mg/1	TabletOral	REMEDYREPACK INC.	70518-4620	70518-4620-00
Carbidopa and Levodopa	Carbidopa 36.25 mg/1; Levodopa 145 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4630	70518-4630-00
Carbidopa and Levodopa	Carbidopa 61.25 mg/1; Levodopa 245 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4610	70518-4610-00
Carbidopa And Levodopa	Carbidopa 25 mg/1; Levodopa 250 mg/1	TabletOral	Coupler LLC	67046-1668	67046-1668-03
Carbidopa and Levodopa	Carbidopa hydrate 25 mg/1; Levodopa 100 mg/1	Tablet, Extended releaseOral	Safecor Health, LLC	48433-015	48433-0015-20
Carbidopa and Levodopa	Carbidopa hydrate 50 mg/1; Levodopa 200 mg/1	Tablet, Extended releaseOral	Safecor Health, LLC	48433-016	48433-0016-20

All 98 Carbidopa and Levodopa NDCs

Other NDCs under NDA 203312

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 203312
Product	Strength	Form · route	Labeler	Product NDC
Carbidopa and Levodopa	Carbidopa 23.75 mg/1; Levodopa 95 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-2139
Carbidopa and Levodopa	Carbidopa 36.25 mg/1; Levodopa 145 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-2140
Carbidopa and Levodopa	Carbidopa 48.75 mg/1; Levodopa 195 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-2141
Carbidopa and Levodopa	Carbidopa 61.25 mg/1; Levodopa 245 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4610
Carbidopa and Levodopa	Carbidopa 48.75 mg/1; Levodopa 195 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4621
Carbidopa and Levodopa	Carbidopa 23.75 mg/1; Levodopa 95 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4618
Carbidopa and Levodopa	Carbidopa 36.25 mg/1; Levodopa 145 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4630
Rytarycarbidopa and levodopa	Levodopa 95 mg/1; Carbidopa hydrate 23.75 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals LLC	64896-661
Rytarycarbidopa and levodopa	Levodopa 145 mg/1; Carbidopa hydrate 36.25 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals LLC	64896-662
Rytarycarbidopa and levodopa	Levodopa 195 mg/1; Carbidopa hydrate 48.75 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals LLC	64896-663
Rytarycarbidopa and levodopa	Levodopa 245 mg/1; Carbidopa hydrate 61.25 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals LLC	64896-664